Curriculum Vitae

PERSONAL INFORMATION Carla Torre

WORK EXPERIENCE

September 2018- Present Invited Assistant Professor Faculty of Pharmacy of the University of Lisbon (Portugal) Assistant Professor for the courses of Pharmacoepidemiology and Pharmacovigilance (head in 2020/21) and Public Health from the Integrated Master of Pharmaceutical Sciences. Carla Torre also lectures other courses from the Master of Regulatory Sciences and PhD courses within the epidemiology, public health, pharmacoepidemiology and pharmacovigilance field sciences.

July 2016- Present Secretary General Portuguese Pharmaceutical Society (Portugal)

December 2016- Present Pharmacoepidemiology Expert Pharmacovigilance Unit of Lisboa, Setubal and Santarém - INFARMED, National Authority of Medicines and Health Products I.P (Portugal)

January 2010-August 2018 Guest Lecturer Faculty of Pharmacy of the University of Lisbon (Portugal)

February 2009-July 2016 Pharmacoepidemiology Project Manager Lead Center of Pharmacoepidemiology and Outcomes Research - National Association of Pharmacies (Portugal)

February 2006-February 2009 Advisor to the National Coordinator for HIV/AIDS Ministry of Health (National Coordination for HIV/AIDS) (Portugal)

EDUCATION AND TRAINING

September 2019-June 2020 Postgraduate Professional Development course in Pharmacoepidemiology and Pharmacovigilance (Certificate of Achievement in Pharmacoepidemiology and Pharmacovigilance) London School of Hygiene & Tropical Medicine (United Kingdom)

February 2012-June 2018 Doctorate degree (PhD) in Pharmacy, specialization in Pharmacoepidemiology Faculty of Pharmacy of the University of Lisbon (Portugal)

June 2015-June 2015 Specialization course in Pharmacoeconomics McGill University (Canada)

May 2015-May 2015 Specialization course in Advanced Pharmacoepidemiology McGill University (Canada)

May 2014-May 2014 Specialization course in Intermediate Pharmacoepidemiology McGill University (Canada)

May 2014-May 2014 Specialization course in Basic Pharmacoepidemiology McGill University (Canada)

29/01/2021 European Medicines Agency Page 1/3 February 2013-February 2013 International Meyler course in Pharmacovigilance University of Groningen (Netherlands)

July 2012-July 2012 Specialization course in Pharmaceutical Policy Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University (Netherlands)

June 2011-July 2011 Specialization course in Pharmacoepidemiology and Drug Safety Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University (Netherlands)

April 2010-May 2010 Post-graduation specialization course in Statistics Applied to Clinical Research NOVA Medical School, New University of Lisbon (Portugal)

October 2006-July 2009 Masters degree (MSc) in Epidemiology Faculty of Medicine of the University of Porto (Portugal)

April 2005-June 2006 Post-graduation Diploma (PgD) in Pharmacy and Medicinal Products Law Faculty of Law of the University of Coimbra (Portugal)

October 1998-June 2004 Pharmaceutical Sciences degree (PharmD) Faculty of Pharmacy of the University of Lisbon (Portugal) Pharmaceutical Sciences and Pharmacy degree with a 5-year curriculum and 6 months internship in community and hospital pharmacy ADDITIONAL INFORMATION

Expertise Pharmacoepidemiology Epidemiology Pharmacovigilance Public Health Publications Carla Torre has authored/co-authored 16 full articles in peer review journals and 5 book chapters/reports. She presented over 70 scientific congress communications (over 20 as oral communications and invited speaker, and others as poster). Selection of published full papers in peer reviewed indexed journals: Al-Musawe L, Torre C, Guerreiro JP, Rodrigues AT, Raposo JF, Mota-Filipe H, Martins AP (2020). Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life. Pharmacol Res Perspect, 8(4):e00621. doi:10.1002/prp2.621. Torre C, Guerreiro J, Longo P, Raposo JF, Leufkens H, Martins AP (2020). Intensive monitoring of adverse drug events associated with the use of new glucose lowering drugs: results from an inception cohort study in Portugal. Diabetic Medicine, 37(4):648-656. doi: 10.1111/dme.14168. Torre C, Cary M, Borges FC, Ferreira PS, Alarcão J, Leufkens HG, Costa J, Martins AP (2019). Intensive Monitoring Studies for Assessing Medicines: A Systematic Review. Front Med (Lausanne), 19;6:147. doi: 10.3389/fmed.2019.00147. Al-Musawe L, Paula Martins A, Filipe Raposo J, Torre C (2019). The Association Between Polypharmacy and Adverse health Consequences in Elderly Type 2 Diabetes Mellitus Patients; a Systematic Review and Meta-analysis. Diabetes Res Clin Pract, 31:107804. doi: 10.1016/j.diabres.2019.107804. Torre C, Guerreiro J, Longo P, Raposo JF, Leufkens H, Martins AP (2019). Health-related quality of life in adults with type 2 diabetes mellitus starting with new glucose lowering drugs: an inception cohort study. Prim Care Diabetes, 13(3):221-232. doi: 10.1016/j.pcd.2018.11.009. Torre C, Guerreiro J, Mendes Z, Miranda A, Bragança F, Cristino J, Canhão H, Branco J (2019). Low Persistence with Oral Bisphosphonate Treatment in Portuguese Women with Postmenopausal Osteoporosis. Acta Reumatólogica Portuguesa, 44(2):114-125. Torre C, Guerreiro J, Longo P, Raposo JF, Leufkens H, Martins AP (2018). Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an

29/01/2021 European Medicines Agency Page 2/3 observational, inception cohort study in Portugal. Patient Prefer Adherence, 12:1471-1482. Torre C, Guerreiro JP, Romano S, Miranda A, Longo P, Alão S, Conceição J, Laires P (2018). Real-world prevalence of mild to moderate hypoglycemic episodes in Portugal: Results from the HIPOS-PHARMA study. Prim Care Diabetes. 2018 Dec;12(6):537-546. Gama H, Torre C, Guerreiro JP, Azevedo A, Costa S, Lunet N (2017). Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal. BMC Health Serv Res. 2017 Jun 29;17(1):449. Fernandes RM, Cary M, Duarte G, Jesus G, Alarcão J, Torre C, Costa S, Costa J, Carneiro AV (2017). Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews. BMC Public Health. 2017 Apr11;17(1):309. Torre C, Guerreiro J, de Oliveira Martins S, Raposo JF, Martins AP, Leufkens H (2015). Patterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over time. Prim Care Diabetes,9(6):482-9. Jacinto I, Costa S, Horta R, Mendes Z, Torre C, Guerreiro J, Queirós S (2015). Vaccination servisse in the Portuguese Pharmacies. Rev Port Farmacoter, 7(3): 160-166. Souto D, Torre C, Mendes Z, Simões J, Falcão I, Ferreira F, Miranda A, Dias C (2013). Therapeutic profile of hypertension in the Physicians Network Sentry: 12 years later. Portuguese Journal of General Practice, 29(5):286-296 Torre C, Lucas R, Barros H (2010). Syringe exchange in community pharmaciesThe Portuguese experience. Int J Drug Policy. 2010 Nov;21(6):514-7. Torre C (2009). Syringe exchange programmes in the context of harm reduction. Arq Med, 23 (9): 119-31. Selection of Book Chapters / Reports: Barao P, Torre C (2018). Spontaneous Reporting. Pharmacovigilance in Portugal: 25 years, Sofia Oliveira Martins (Editor), Portuguese National Authority for Medicines and Health Products - INFARMED, pp:163-176, ISBN 978-989-836916-1. Gomes M, Torre C, Furtado C (2017). Pattern of antibiotic consumption and association with bacterial resistance in Portugal, 2004-2014. In Spring Report 2017 - Health Systems Portuguese Observatory. Available on: http://opss.pt/relatorios/relatorio-primavera-2017/. Torre C, Martins AP (2012). Overview of pharmacoepidemiological databases in the assessment of medicines under real-Life conditions. In Epidemiology - Current Perspectives on Research and Practice, Nuno Lunet (Ed.), In Tech, pp. 131-154, ISBN: 978-953-51-0382-0, Croatia.

Projects Memberships Member of the International Society for Pharmacoepidemiology (since 2009), being actively involved in the Special Interest Group (SIG) of Drug Utilization and Health Services Research. Member of the Board of the Scientific Society for Clinical Pharmacy and Pharmacotherapy (since 2016). Member of the Portuguese Association of Epidemiology (since 2006). Member of the National Commission for Public Health Reform, Directorate-General for Health, Ministry of Health (2016-20). Member of the Scientific Council of the National Programme for Diabetes, Directorate-General for Health, Ministry of Health (since 2018).

Other Relevant Information

29/01/2021 European Medicines Agency Page 3/3